TOVX
#4659
Theriva Biologics, Inc. Common Stock
0.1 7 USD
-0.06%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-5.56%
Changement Mensuel
-26.09%
Evolution sur 6 mois
-53.19%
Changement Annuel
-31.34%
Clôture Précédente
0.1 8
Open
0.1 7
Low
0.1 4
High
0.1 7
Financials
- Market Capitalization 7.8 M
- Employee 16
- Founded 1986
- CEO N/A
- Website www.therivabio.com
- Headquarter Nevada, United States
- FIGI BBG000BV6QX8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.1
ratio cours/chiffre d'affaires
102.18
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4654 |  MBRX Moleculin Biotech, Inc. - Common Stock | 8.16 USD | -3.55% | -6.31% | +1565.31% | +159.05% | 7.95 M USD | ||
| 4655 |  ACTU Actuate Therapeutics, Inc. - Common stock | 0.33 USD | -10.81% | -10.81% | -62.92% | -91.91% | 7.92 M USD | ||
| 4661 |  QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 3.84 USD | -2.78% | -8.35% | -14.29% | -58.80% | 7.71 M USD | ||
| 4663 |  BLRX BioLineRx Ltd - American Depositary Shares | 1.77 USD | -5.35% | -11.06% | -23.04% | -37.01% | 7.70 M USD |
Frequently asked questions about Theriva Biologics, Inc.
What is the Theriva Biologics, Inc. stock price today?
The current price of Theriva Biologics, Inc. (TOVX) is 0.17. Over the past 24 hours, the stock has changed by -5.56%. Follow the TOVX chart for real-time price dynamics.
What is the stock ticker of Theriva Biologics, Inc.?
Theriva Biologics, Inc. trades under the ticker TOVX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Theriva Biologics, Inc. stock going up?
TOVX has changed by -10.53% over the last week, -26.09% over the last month, and -31.34% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Theriva Biologics, Inc.?
Theriva Biologics, Inc. currently has a market capitalization of 7.8 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Theriva Biologics, Inc. release financial reports?
Yes. You can track Theriva Biologics, Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Theriva Biologics, Inc. earnings last quarter?
Last quarter, Theriva Biologics, Inc. reported earnings of -0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Theriva Biologics, Inc. revenue for the last quarter?
Theriva Biologics, Inc. reported quarterly revenue of 1 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Theriva Biologics, Inc. net income for the last quarter?
Theriva Biologics, Inc. reported net income of -3.22 M for the last quarter. The previous quarter showed -2.04 M, which means net income changed by -57.39%.
How many employees does Theriva Biologics, Inc. have?
As of the latest available data, Theriva Biologics, Inc. has 16 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Theriva Biologics, Inc. stock?
You can buy Theriva Biologics, Inc. (TOVX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Theriva Biologics, Inc. stock?
Investing in Theriva Biologics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TOVX chart and related analysis on metatrader.com as part of your research.